Authors: ESMAIL AF DUPE RJ GODDARD M BRIGGS I LUPU F KAKKAR VV

Citation: Af. Esmail et al., COMPARISION OF ANTITHROMBOTIC PROPERTIES OF TRIBAN, HIRUDIN, HEPARIN AND ASPIRIN IN A NEW DYNAMIC-MODEL OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 368-368

Authors: ESMAIL AF SCULLY MF DUPE RJ DEADMAN JJ GOODWIN CG BRIGGS IM GODDARD M KAKKAR VV

Citation: Af. Esmail et al., EFFECT OF TRIBAN A NOVEL THROMBIN INHIBITOR ON PLATELET PROCOAGULANT ACTIVITY IN-VITRO AND SK INDUCED THROMBOLYSIS IN-VIVO, Thrombosis and haemostasis, 1997, pp. 2037-2037

Authors: GODDARD M ESMAIL AF DUPE RJ BRIGGS I DEADMAN J SCULLY MF KAKKAR VV

Citation: M. Goddard et al., PHARMACOKINETICS AND BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN RATS FOLLOWING INTRAVENOUS AND INTRADUODENAL ADMINISTRATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1308-1308

Authors: ESMAIL AF DUPE RJ GODDARD M BRIGGS IM BABBAN JA ELGENDY S GREEN D DEADMAN J SCULLY MF KAKKAR VV

Citation: Af. Esmail et al., ANTITHROMBOTIC AND ANTICOAGULANT PROPERTIES OF NOVEL PEPTIDE BORONIC ACID THROMBIN INHIBITORS - COMPARISON WITH HEPARIN AND HIRUDIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1318-1318

Authors: WILSON S CRONK DW DODD I ESMAIL AF KALINDJIAN SB MCMURDO L BROWNE MJ SMITH RAG ROBINSON JH

Citation: S. Wilson et al., THE USE OF ACTIVE-CENTER ACYLATION TO CONTROL THE PHARMACOKINETIC PROFILE OF A RECOMBINANT CHIMERIC PLASMINOGEN-ACTIVATOR, Thrombosis and haemostasis, 70(6), 1993, pp. 984-988

Authors: BROWNE MJ CAREY JE CHAPMAN CG DODD I ESMAIL AF LAWRENCE GMP MCMURDO L WILLIAMSON I WILSON S ROBINSON JH

Citation: Mj. Browne et al., PROTEIN ENGINEERING AND COMPARATIVE PHARMACOKINETIC ANALYSIS OF A FAMILY OF NOVEL RECOMBINANT HYBRID AND MUTANT PLASMINOGEN ACTIVATORS, Fibrinolysis, 7(6), 1993, pp. 357-364